The largest database of trusted experimental protocols

Puromycin selection

Manufactured by Solarbio
Sourced in United States

Puromycin is an antibiotic commonly used as a selective agent in cell culture to identify and maintain cells that have been successfully transfected or transduced with a gene of interest. It works by inhibiting protein synthesis, leading to cell death in untransfected cells.

Automatically generated - may contain errors

5 protocols using puromycin selection

1

Overexpression of YAP1 in Colon Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirus particles expressing YAP1 were produced by GenePharma Co. Ltd. China. HT-29, and Caco-2 cells were transfected with the Lentivirus particles using an LV5 vector with a YAP1 insert. Stably transfected cells with GFP were sorted using flow cytometry (BD FACS Aria II; BD Biosciences, Franklin Lakes, NJ, USA) and isolated using puromycin selection (Solarbio, Beijing, China).
+ Open protocol
+ Expand
2

Lentiviral Silencing of LMNB1 in Liver Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentiviral small hairpin RNA targeting LMNB1 (lv-sh-LMNB1) and empty lentiviral vector (lv-sh-con) were purchased from Hanbio (Shanghai, China). The sequence of sh-LMNB1 was 5’- GATCCGCGCTTGAAGAACACTTCTGAATTCAAGAGATTCAGAAGTGTTCTTCAAGCGTTTTTTG -3’. HepG2 and Hep3B cells were infected with lentivirus to construct stably transfected cell lines. After 72 h, we removed negative cells through puromycin selection (Solarbio).
+ Open protocol
+ Expand
3

Lentiviral-mediated NK1R Modulation in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
NK1R knockdown was performed as previously described [23 (link)]. The lentivirus particles containing shNK1R were obtained from OBIO Technology (Shanghai, China). The shRNA sequences were cloned into lentiviral vector pLKD-CMV-EGFP-Puro respectively (shctrl: 5´-TTCTCCGAACGTGTCACGT-3´; shNK1R 1#: 5´-GCAACCAGCCTG GCAAATT-3´; shNK1R2#: 5´-GCCTGTTCTACTGCAAGTT-3´). Cells were transfected with the lentivirus particles according to the manufacturer’s instructions followed by puromycin selection (5 μg/ml, Solarbio, Beijing, China). For NK1R overexpression, pLenti-EGFP-Puro-CMV-NK1R plasmid (OBIO) was transfected into cells with GC Liposomal Transfection Reagent (Genecarer, Xi’an, China) followed with puromycin selection.
A dual sgRNA CRISPR/Cas9 system was used to delete the ARE1 sequence in the enhancer region of the NK1R gene. Briefly, sgRNA sequences (sgRNA-F: 5’-GTACGA ATAGCCATCATATCCTGG -3’; sgRNA-R: 5’-GTCCTAAGAGCATTACACCTG AGG-3’) were cloned into the vector of Lenti-CRISPR-dual gRNA. The cells were transfected with Lenti-CRISPR-dual gRNA-ARE1 or vector control plasmid with GC Liposomal Transfection Reagent for 48 h, then harvested for the analysis of ARE1 deletion efficiency using Takara ExTaq PCR kit (Dalian, China) with the forward primer 5’-AGCGGTTTCCCAGTAGAGTC-3’ and the reverse primer 5’-AAGGGTTCAGCATGTTCTGC-3’.
+ Open protocol
+ Expand
4

Ascl2 Lentivirus Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirus particles expressing Ascl2 were produced by GenePharma Co. Ltd (Shanghai, China). Lovo and SW480 cells were transfected with lentivirus particles using LV5 (EF-1aF/GFP&Puro) vector with Ascl2 insert. Stably transfected cells with GFP were sorted with a flow-cytometric sorting system (BD FACS Aria II; BD Biosciences, Franklin Lakes, NJ, USA) or isolated under puromycin selection (Solarbio, Beijing, China).
+ Open protocol
+ Expand
5

Lentiviral Transduction of Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were maintained in DMEM/F12 supplemented with B27 (Gibco), human epidermal growth factor (hEGF, PeproTech, 20 ng/mL), and human fibroblast growth factor (hFGF, PeproTech, 20 ng/mL) for GSCs, or in DMEM containing 10% FBS and penicillin-streptomycin for U87 cell lines, or in RPMI-1640 supplemented with 10% FBS and penicillin-streptomycin for LNCaP cell lines. Cell lines were transduced with either pLV-HSV-TK promoter-hluciferase-hef1a-eGFP-P2A-neo or pLV-HSV-TK promoter-hluciferase-hef1a-mScarlet-P2A-neo lentivirus and subsequently sorted under G-418 selection (400 μg/mL, Solarbio) for a minimum of two weeks. To generate different EGFRvIII densities, luciferase-eGFP+ U87 cells underwent fluorescence-activated cell sorting following transduction with the pLV-HSV-TK promoter-EGFRvIII-puro lentivirus.44 (link) Concurrently, pLV-HSV-TK promoter-EGFRvIII-eGFP-puro lentivirus was transduced into U87 cells under puromycin selection (0.5–5 μg/mL, Solarbio) for at least two weeks.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!